Whitehawk Therapeutics, Inc. (WHWK)
3.07
+0.05
(+1.66%)
USD |
NASDAQ |
Nov 06, 10:20
Whitehawk Therapeutics EPS Diluted (Quarterly) : -0.2008 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2008 |
| March 31, 2026 | -0.3206 |
| December 31, 2025 | -0.3359 |
| September 30, 2025 | -0.2564 |
| June 30, 2025 | -0.7616 |
| March 31, 2025 | 1.828 |
| December 31, 2024 | -0.6746 |
| September 30, 2024 | -0.464 |
| June 30, 2024 | -0.5399 |
| March 31, 2024 | -0.6778 |
| December 31, 2023 | -0.6033 |
| September 30, 2023 | -0.605 |
| June 30, 2023 | -0.6686 |
| March 31, 2023 | -0.5667 |
| December 31, 2022 | -0.5184 |
| September 30, 2022 | -0.6805 |
| June 30, 2022 | -0.8712 |
| March 31, 2022 | -0.6625 |
| December 31, 2021 | -0.7654 |
| Date | Value |
|---|---|
| September 30, 2021 | -9.173 |
| June 30, 2021 | -9.062 |
| March 31, 2021 | -32.31 |
| December 31, 2020 | 45.86 |
| September 30, 2020 | -18.52 |
| June 30, 2020 | 3.402 |
| March 31, 2020 | -1.448 |
| December 31, 2019 | -1.643 |
| September 30, 2019 | -1.718 |
| June 30, 2019 | -2.100 |
| March 31, 2019 | -3.139 |
| December 31, 2018 | -3.148 |
| September 30, 2018 | 4.225 |
| June 30, 2018 | -3.30 |
| March 31, 2018 | -4.05 |
| December 31, 2017 | -3.45 |
| September 30, 2017 | -2.590 |
| June 30, 2017 | -3.15 |
| March 31, 2017 | -15.90 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 7.077 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.1417 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.64M |
| Total Expenses (Quarterly) | 16.64M |
| Enterprise Value | -17.81M |
| Earnings Yield | -36.28% |
| Normalized Earnings Yield | -36.28 |